Antifungal activity of curcumin-silver nanoparticles against fluconazole-resistant clinical isolates of Candida species

INTRODUCTION: Candida species is the common form of opportunistic fungal infections, especially in immunosuppressed individuals. Fluconazole is the first-line therapy for candidiasis as it is affordable and readily available. However, the antifungal resistance pattern in high-risk patients is a majo...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Sony, Mohanram, Kalyani, Kannan, Iyanar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2018
Materias:
Pharmacological Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454909/
https://www.ncbi.nlm.nih.gov/pubmed/31000996
http://dx.doi.org/10.4103/ayu.AYU_24_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454909/
https://www.ncbi.nlm.nih.gov/pubmed/31000996
http://dx.doi.org/10.4103/ayu.AYU_24_18

Ejemplares similares